Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The methylation pathway via S-adenosylmethionine (SAM) is a fundamental cellular process where SAM acts as the primary methyl group donor for methylation reactions. It is essential for gene regulation, epigenetic modification, neurotransmitter synthesis, detoxification, and overall metabolic function. Disturbances in this pathway are linked to various diseases, and modulation has been explored therapeutically.
SAM acts as a methyl donor, facilitating the transfer of methyl groups to various substrates. Modulation of enzymes involved in the pathway affects overall methylation capacity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylation Pathway via S-adenosylmethionine (SAM) (SAM Methylation Pathway).